Human CD21/CR2/EBV receptor quantitates human CD21/CR2/EBV receptor in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD21/CR2/EBV receptor.
Human CD21/CR2/EBV receptor quantitates human CD21/CR2/EBV receptor in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CD21/CR2/EBV receptor.
CD21 (Supplement receiver 2, CR2 receiver, C3D receiver, EBV receiver) binds C3 complement fragments, in particular its degradation fragments, which remain covalently bound to complement the activation surfaces or antigen. CD21 plays an important role in the absorption and retention of immunocomplexes, the survival of memory B cells, and in the development and maintenance of the humoral reaction to T-cell dependent antigens. CD21 also serves as a key receptor for Epstein-Barr binding and is involved in targeting prion on follicular dendritic cells and accelerating neuroinvasion after peripheral exposure to prions. A soluble form of CD21 (sCD21) is released from the lymphocyte surface and retains its ability to bind the respective ligands. The CD21 serves as a receiver for C3d, C3dg and iC3b complementary components, for the EBV and for the IFNalpha. CD21 binds to CD23 and joins CD19, CD81 and Leu13 to form a large signal transduction complex involved in B cell activation. Genetic variations in the CD21 gene are associated with sensitivity to disseminated lupus erythematosus 9 (SLEB9). Alternative splicing transcription variants that code different CD21 isoforms were also found.
Sensitivity
Sensitivity of the dosage: 17 pg/ml.
Measurement range
Dose range: 17 to 4,000 pg/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17115319 |
| Specifications |
| Accession number | C3DR; CD21; CD35; cell surface receptor for C3d; C3d receiver complementary; C3d receiver complementary 2; C3d receiver complementary 1 (3 b/4 b) (Knops blood group); C3d receiver complementary 2 (3 d/Epstein Barr virus); Comp component receptor |
| Dose range | 17 to 4.000 pg/ml |
| Sensitivity of the dosage | 17 pg/ml |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P20023 |
| Gene symbol(s) | CR2 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | Use exclusively for research |
| Target | CD21 |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; plasma, 50 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EH81RBX5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.